Canopy Growth Corp (NASDAQ:CGC) Share Price

Company Profile

Business description
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Contact
1 Hershey Drive
Smiths FallsONK7A 0A8
CAN
T: +1 855 558-9333
https://www.canopygrowth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,128

Recommended

Companies with US exposure are better positioned to benefit from easing prohibition, writes Kristoffer Inton.

Kristoffer Inton | 26 October 2020

Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.

Susan Dziubinski | 01 October 2020

In ten years’ time, you won’t be illegally smoking cannabis, you’ll be legally eating it. Here are some stocks to watch.

Lex Hall | 22 September 2020

Index	Last price	Change	% Change
All Ordinaries	8,977.20	48.20	-0.53%
CAC 40	8,047.69	78.27	0.98%
DAX 40	25,981.09	162.88	0.63%
Dow JONES (US)	51,983.98	213.67	0.41%
FTSE 100	10,761.33	31.55	0.29%
HKSE	23,393.32	98.90	0.42%
NASDAQ	25,164.31	272.68	-1.07%
Nikkei 225	63,081.86	208.25	-0.33%
NZX 50 Index	13,654.84	43.79	-0.32%
S&P 500	7,541.40	38.67	-0.51%
S&P/ASX 200	8,856.50	51.60	-0.58%
SSE Composite Index	3,638.03	39.01	1.08%